Lupin launches fixed dose triple combo inhaler for COPD in India
Lupin | Photo Credit: Reuters Drugmaker Lupin has launched Formoflo-G MDI, a fixed-dose triple combination metered-dose inhaler for chronic obstructive pulmonary disease (COPD) in India following approval from the Drug Controller General of India (DCGI). Formoflo-G is a first-of-its-kind MDI that combines Glycopyrronium Bromide, Formoterol Fumarate and Fluticasone Propionate for the long-term management and treatment…
Read More “Lupin launches fixed dose triple combo inhaler for COPD in India” »